Collection 專利 [0/1] 期刊論文 [19/19] Siblings 伍素瑩 [53/66] 其他 [58/60] 夏克山 [77/157] 岳嶽 [29/32] 張仲明 [7/9] 張竣評 [21/38] 徐祖安 [170/229] 李秀珠 [76/106] 李靜琪 [24/25] 林書玉 [21/22] 洪明秀 [32/41] 潘秀玲(2009-2013) [16/17] 王文傑 [13/15] 王鴻俊 [7/7] 石全(2014-2017) [36/73] 童俊維 [24/24] 紀雅惠 [21/25] 翁紹華 [23/25] 莊宏 [1/1] 葉修華 [25/26] 葉燈光 [135/154] 蔣維棠 [43/81] 謝興邦 [178/242] 趙宇生(2002-2013) [120/242] 郭靜娟 [51/57] 鄒倫 [28/63] 陳志豪 [31/52] 陳新(2002-2015) [53/67] 陳炯東 [183/249] 顏婉菁 [6/7] 許明珠(1997-2001) [3/10] 陳淑貞(1998-2001) [3/11] 陳華鍵(1997-2001) [9/9] Community Statistics 近3年內發表的文件:9(45.00%) 含全文筆數:19(95.00%) 文件下載次數統計 下載大於0次:19(100.00%) 下載大於100次:17(89.47%) 檔案下載總次數:4310(0.08%) 最後更新時間: 2025-02-21 17:07 Top Upload Loading... Top Download Loading... Recent Submissions 嘧啶化合物及其用途 Advancing precision therapy for col... Macrophage-mediated controlled rele... Targeting cathepsin S promotes acti... Lysosomal-targeted doxorubicin deli... How to deal with frenemy NRF2: Targ... Synthesis and structure–activity re... The synergistic inhibition of coron... MiR-455-5p suppresses PDZK1IP1 to p... The synergistic inhibition of coron...

Jump to a point in the index: (Choose year) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-20 of 20. (1 Page(s) Totally) 1  View [10|25|50] records per page

Date	Title	Relation
2025-01	Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models	Pharmacological Research. 2025 Jan;211:Article number 107556.
2024-06-24	Macrophage-mediated controlled release of cysteine protease inhibitor from PLGA-PEG/hydroxyapatite microspheres for targeting cathepsin S in Alzheimer's disease	European Polymer Journal. 2024 Jun 24;214:Article number 113151.
2024-05-09	Targeting cathepsin S promotes activation of OLF1-BDNF/TrkB axis to enhance cognitive function	Journal of Biomedical Science. 2024 May 09;31:Article number 46.
2023-11	Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death	Pharmacological Research. 2023 Nov;197:Article number 106945.
2023-10-11	嘧啶化合物及其用途	TWI818651/2023-10-11
2023-03-28	Synthesis and structure–activity relationship of salvinal derivatives as potent microtubule inhibitors	International Journal of Molecular Sciences. 2023 Mar 28;24(7):Article number 6386.
2023-02-28	How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy	Journal of Food and Drug Analysis. 2023 Feb 28;31(3):387-407.
2023-02-03	MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition	Journal of Experimental and Clinical Cancer Research. 2023 Feb 3;42:Article number 40.
2023-01-19	The synergistic inhibition of coronavirus replication and induced cytokine production by ciclesonide and the tylophorine-based compound dbq33b [Erratum:Pharmaceutics. 2022 Jul 21;14(7):Article number 1511.]	Pharmaceutics. 2023 Jan 19;15(2):Article number 342.
2022-07-21	The synergistic inhibition of coronavirus replication and induced cytokine production by ciclesonide and the tylophorine-based compound dbq33b	Pharmaceutics. 2022 Jul 21;14(7):Article number 1511.
2022-03-16	Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca2+ release in cancer cells	Cell Death and Disease. 2022 Mar 16;13(3):Article number 241.
2022-03-02	Discovery of potential neuroprotective agents against paclitaxel-induced peripheral neuropathy	Journal of Medicinal Chemistry. 2022 Mar 2;65(6):4767-4782.
2021-12-14	A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells	Journal of Food and Drug Analysis. 2021 Dec 14;29(4):638-652.
2021-11-09	MicroRANs: Their role in metabolism, tumor microenvironment, and therapeutic implications in head and neck squamous cell carcinoma	Cancers. 2021 Nov 9;13(22):Article number 5604.
2021-08-13	Remdesivir and cyclosporine synergistically inhibit the human coronaviruses OC43 and SARS-CoV-2	Frontiers in Pharmacology. 2021 Aug 13;12:Article number 706901.
2021-06	Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer	Cancer Medicine. 2021 Jun;10(12):4075-4086.
2021-03-11	c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation	Theranostics. 2021 Mar 11;11(11):5232-5247.
2021-03-04	Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy	Theranostics. 2021 Mar 4;11(10):4672-4687.
2021-03-01	Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors	Scientific Reports. 2021 Mar 1;11:Article number 4834.
2021-02-24	New insights into oral squamous cell carcinoma: From clinical aspects to molecular tumorigenesis	International Journal of Molecular Sciences. 2021 Feb 24;22(5):Article number 2252.

Showing items 1-20 of 20. (1 Page(s) Totally) 1  View [10|25|50] records per page